Abstract
The isolation of the human T-cell leukaemia (lymphotropic) virus type III (HTLV-III or lymphadenopathy-associated virus) from cells of many patients with acquired immune deficiency syndrome (AIDS)1,2 presented the first evidence that the virus was the aetio-logical agent of the disease. Subsequent seroepidemiological studies have shown the presence of HTLV-III-specific antibodies in the serum of most patients with AIDS and AIDS-related complex (ARC)3,4, and in the serum of many individuals at risk for AIDS3–14. Despite these extensive studies, there are no reports of protective effects of HTLV-III antibodies. In contrast, neutralizing antibodies specific for HTLV-I and -II have been identified previously15. Therefore, we investigated whether HTLV-III-exposed individuals possess antibody activities capable of inhibiting viral infection (see also refs 16, 17). Here, we report that natural antibodies capable of neutralizing HTLV-III infection of H9 cells were detected in most adult AIDS and ARC patients but in no normal healthy heterosexual controls. Geometric mean antibody titres in ARC patients were double those in AIDS patients, and were even higher in two antibody-positive healthy homosexuals. This suggests that virus neutralizing antibodies may exert an in vivo protective effect. The presence of these antibodies indicates an immunological response to HTLV-III which potentially may be manipulated for therapeutic advantage. The methodology used here will be useful in monitoring future vaccine approaches.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Popovic, M., Sarngadharan, M. G., Read, E. & Gallo, R. C. Science 224, 497–500 (1984).
Gallo, R. C. et al. Science 224, 500–502 (1984).
Sarngadharan, M. G., Popovic, M., Bruch, L., Schupbach, J. & Gallo, R. C. Science 224, 506–508 (1985).
Safai, B. et al. Lancet i, 1438–1440 (1984).
Goedert, J. J. et al. Lancet ii, 711–716 (1984).
Tsoukas, C. et al. New Engl. J. Med. 311, 1514–1515 (1984).
Goedert, J. J. et al. Blood 65, 492–495 (1985).
Gazzolo, L., Gessain, A., Robin, Y., Robert-Guroff, M. & de-The, G . New Engl. J. Med. 311, 1252–1253 (1984).
Redfield, R. R. et al. J. Am. med. Ass. 253, 1571–1573 (1985).
Harris, C. A. et al. (in preparation).
Clumeck, N. et al. New Engl. J. Med. 310, 492–497 (1984).
Saxinger, W. C. et al. Science 227, 1036–1039 (1985).
Clumeck, N. et al. (in preparation).
Gazzolo, L. et al. Int. J. Cancer (in the press).
Clapham, P., Nagy, K. & Weiss, R. A. Proc. natn. Acad. Sci. U.S.A. 81, 2886–2889 (1984).
Weiss, R. A. et al. Nature 316, 69–72 (1985).
McDougal, J. S. et al. J. immun. Meth. 76, 171–183 (1985).
Veronese di Marzo, F. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
Steeves, R. A., Strand, M. & August, J. T. J. Virol 14, 187–189 (1974).
Ihle, J. N. & Lazar, B. J. Virol. 21, 974–980 (1977).
Narayan, O., Clements, J. E., Griffin, D. E. & Wolinsky, J. S. Infect. Immun. 32, 1045–1050 (1981).
Shaw, G. M. et al. Science 226, 1165–1171 (1984).
Gonda, M. A. et al. Science 227, 173–177 (1985).
Robert-Guroff, M., Ruscetti, F. W., Posner, L. E., Poiesz, B. J. & Gallo, R. C. J. exp. Med. 154, 1957–1964 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robert-Guroff, M., Brown, M. & Gallo, R. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature 316, 72–74 (1985). https://doi.org/10.1038/316072a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/316072a0
This article is cited by
-
The expanding array of HIV broadly neutralizing antibodies
Retrovirology (2018)
-
Selective alterations of the antibody response to HIV-1
Applied Biochemistry and Biotechnology (1998)
-
Specific cytotoxic T cells eliminate cells producing neutralizing antibodies
Nature (1996)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.